查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1539331

聚己內酯市場：2024-2032年全球產業分析、規模、佔有率、成長、趨勢、預測

Polycaprolactone Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032
出版日期: | 出版商: Persistence Market Research | 英文 300 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發布了一份有關全球聚己內酯市場的詳細報告。本報告對關鍵市場動態進行了全面分析，包括驅動因素、趨勢、機會和挑戰，提供了對市場結構的深入見解。

關鍵見解

  • 聚己內酯市場規模（2024年）：6.697億美元
  • 市場預測金額（2032年）：13.652億美元
  • 全球市場成長率（2024-2032年年複合成長率）：8.2%

聚己內酯市場：研究範圍

聚己內酯市場涵蓋多種應用和產品，特別是在生物分解塑膠、樹脂和醫療設備的生產中。聚己內酯（PCL）是一種低熔點、生物分解的聚酯，廣泛用作熱塑性聚氨酯、生物醫學材料和藥物傳輸系統的成分。市場涵蓋生物醫學領域、包裝產業、特種化學品等多個領域。成長的推動因素包括日益成長的環境問題導致對生物分解材料的需求、醫療技術的進步以及 PCL 在各種工業過程中的廣泛使用。

推動市場成長的因素：

推動全球聚己內酯市場有幾個關鍵因素。在環境法規和消費者意識的推動下，對生物分解塑膠的需求不斷成長，顯著推動市場發展。聚己內酯與其他聚合物混合的多功能性擴大了其在包裝和醫療行業的用途。此外，組織工程、藥物傳輸和縫合線等生物醫學應用的擴大也推動了市場的擴張。這種材料易於加工且與各種製造技術相容，使其成為製造客製化設計的生物醫學設備的最愛，支持市場的穩定成長。

市場限制因素：

儘管成長前景廣闊，但聚己內酯市場面臨著與 PCL 生產相關的高成本和更便宜的替代品的可用性等挑戰。與傳統聚合物相比，聚己內酯的製造過程可能很昂貴，這可能會限制其在成本敏感市場的採用。此外，聚乳酸（PLA）和聚羥基脂肪酸酯（PHA）等替代生物降解材料的存在也可能具有競爭力，因為它們通常可以以較低的成本獲得。另一個好處是，某些地區對 PCL 益處的認識較低，這可能會阻礙市場成長。

市場機會：

聚己內酯日益用於藥物輸送系統和3D列印等高價值應用，市場存在巨大機會。對個人化醫療和患者特定植入物的需求不斷成長，為基於 PCL 的產品提供了機會，可以根據個人需求提供可自訂的特性。目的是增強機械性能和生物降解性的新型 PCL 複合材料和共混物的開發預計將滿足生物醫學和包裝行業日益成長的需求。此外，不斷發展的循環經濟和永續發展舉措為廣泛採用聚己內酯作為傳統塑膠的環保替代品提供了肥沃的土壤。

本報告解決的關鍵問題

  • 推動全球聚己內酯市場成長的關鍵因素是什麼？
  • 不同產業中使用的聚己內酯有哪些種類和應用？
  • 技術進步如何影響聚己內酯市場的競爭格局？
  • 誰是聚己內酯市場的主要參與者？
  • 全球聚己內酯市場的新趨勢和未來前景如何？

目錄

第1章 執行摘要

第2章 市場介紹

  • 市場分類
  • 市場定義

第3章 市場前景

  • 母市場前景
  • 價值鏈分析
  • 生命週期分析
  • 聚己內酯的能源需求
  • 主要法規
  • 宏觀經濟因素
  • 預測因子：相關性和影響

第4章 市場動態

  • 市場驅動因素
  • 市場限制
  • 市場趨勢
  • 市場機會

第5章 COVID-19 對市場的影響

  • 新冠肺炎（COVID-19）的現狀
  • 各國國家封鎖的影響
  • COVID-19 危機的經濟影響情景
  • 全球受冠狀病毒爆發影響的產業
  • 受災最嚴重產業的復甦預測
  • 冠狀病毒對工作世界的影響
  • 新冠肺炎（COVID-19）對製造業的影響
  • 2024年製造業採購經理指數
  • 新冠肺炎（COVID-19）對全球供應鏈的影響
  • COVID-19 大流行期間的規劃與管理
  • 企業領導者應關注的未來指南

第6章 COVID-19 對聚己內酯市場的影響

  • COVID-19 對聚己內酯市場的影響和價值：依國家/地區劃分，2020年
  • 聚己內酯銷售預測：2020年 COVID-19 大流行期間
  • COVID-19 之前的市場預測與 COVID-19 之後的市場預測

第7章 全球聚己內酯市場分析

  • 簡介
    • 市場金額預測
    • 市場規模（MT）預測
    • 市場規模及年成長率
    • 絕對數量的機會
  • 世界價格分析
  • 強度映射

第8章 全球聚己內酯市場分析：依形式

  • 簡介
  • 2019-2023年歷史市場規模（百萬美元）和數量（公尺）分析：依形式
  • 2024-2032年當前市場規模（百萬美元）和數量（公尺）分析和預測：依形式
    • 顆粒
    • 奈米球
    • 微球
  • 市場吸引力分析：依格式

第9章 全球聚己內酯市場分析：依生產方法

  • 簡介
  • 2019-2023年歷史市場規模（百萬美元）和產量（公尺）分析：依生產方法
  • 2024-2032年當前市場規模（百萬美元）和產量（公尺）的分析和預測：依生產方法
    • 開環聚合
    • 羧酸的縮聚
  • 地方吸引力分析：依生產方法

第10章 全球聚己內酯市場分析：依應用

  • 簡介
  • 2019-2023年歷史市場規模（百萬美元）和數量（公尺）分析：依應用
  • 2024-2032年當前市場規模（百萬美元）和數量（公尺）分析和預測：依應用
    • 熱塑性聚氨酯
    • 醫療保健
    • 其他
  • 市場吸引力分析：依平台

第11章 全球聚己內酯市場分析：依地區

  • 2019-2023年依地區歷史市場規模（百萬美元）及數量（公尺）分析
  • 2024-2032年依地區劃分的當前市場規模（百萬美元）和數量（公尺）分析和預測
    • 北美
    • 拉丁美洲
    • 歐洲
    • 東南亞和太平洋地區（SEAP）
    • 中東和非洲（MEA）
    • 日本
    • 中國
  • 市場吸引力分析：依地區劃分

第12章 北美聚己內酯市場分析

第13章 拉丁美洲聚己內酯市場分析

第14章 歐洲聚己內酯市場分析

第15章 東南亞和太平洋地區（SEAP）聚己內酯市場分析

第16章 中國聚己內酯市場分析

  • 簡介
  • 2019-2023年依細分市場劃分的歷史市場規模（百萬美元）和數量（公尺）分析
  • 2024-2032年依細分市場劃分的市場規模（百萬美元）和數量（公尺）預測
    • 依形式
    • 依生產方式
    • 依用途
  • 市場吸引力分析

第17章 日本聚己內酯市場分析

第18章 中東與非洲（MEA）聚己內酯市場分析

第19章 競爭狀況（製造業）

  • 市佔率分析
  • 競爭狀況
  • 市佔率分析
  • 競爭儀表板
  • 公司簡介
    • Perstorp Holding A. B.
    • BASF SE
    • Diacel Corporation
    • Sigma-Aldrich Corporation（Merck）
    • Durect Corporation
    • Corbion Purac
    • Shenzen Esun Industrial Co. Ltd.
    • Haihang Industries Co., Ltd.
    • Polysciences, Inc.
    • Shenzhen Polymtek Biomaterial Co. Ltd.

第20章 研究方法

第21章 使用的先決條件與縮寫

簡介目錄
Product Code: PMRREP4522

Persistence Market Research has recently published an extensive report on the global Polycaprolactone Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

  • Polycaprolactone Market Size (2024E): USD 669.7 Mn
  • Projected Market Value (2032F): USD 1,365.2 Mn
  • Global Market Growth Rate (CAGR 2024 to 2032): 8.2%

Polycaprolactone Market - Report Scope:

The Polycaprolactone Market encompasses a variety of applications and products, particularly in the manufacturing of biodegradable plastics, resins, and medical devices. Polycaprolactone (PCL) is a biodegradable polyester with a low melting point, widely used in the production of thermoplastic polyurethanes, biomedical materials, and as a component in drug delivery systems. The market caters to diverse segments, including the biomedical sector, packaging industry, and specialty chemicals. Growth is driven by increasing environmental concerns leading to the demand for biodegradable materials, advancements in medical technology, and the expanding application of PCL in various industrial processes.

Market Growth Drivers:

Several key factors are driving the global Polycaprolactone Market. The rising demand for biodegradable plastics, spurred by environmental regulations and consumer awareness, significantly boosts the market. Polycaprolactone's versatility in blending with other polymers enhances its application in the packaging and medical industries. Additionally, the growing biomedical applications, particularly in tissue engineering, drug delivery, and sutures, further fuel market expansion. The material's ease of processing and compatibility with various manufacturing techniques make it a preferred choice for creating custom-designed biomedical devices, which supports the market's steady growth.

Market Restraints:

Despite promising growth prospects, the Polycaprolactone Market faces challenges related to the high costs associated with PCL production and the availability of cheaper alternatives. The production process for polycaprolactone can be more expensive compared to conventional polymers, which can limit its adoption in cost-sensitive markets. Furthermore, the presence of alternative biodegradable materials, such as polylactic acid (PLA) and polyhydroxyalkanoates (PHA), may pose competition, as they are often available at lower costs. Additionally, the market's growth may be hindered by the limited awareness of PCL's benefits in some regions, necessitating greater educational and marketing efforts to promote its advantages.

Market Opportunities:

The market presents significant opportunities driven by the increasing adoption of polycaprolactone in high-value applications, such as drug delivery systems and 3D printing. The growing demand for personalized medicine and patient-specific implants creates opportunities for PCL-based products, which offer customizable properties tailored to individual needs. The development of novel PCL composites and blends, designed to enhance mechanical properties and biodegradability, is expected to cater to the growing demand in the biomedical and packaging industries. Moreover, the expansion of the circular economy and sustainability initiatives provides a fertile ground for the broader adoption of polycaprolactone as an eco-friendly alternative to traditional plastics.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Polycaprolactone Market globally?
  • Which types and applications of polycaprolactone are leading the adoption in various industries?
  • How are technological advancements influencing the competitive landscape of the Polycaprolactone Market?
  • Who are the key players in the Polycaprolactone Market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global Polycaprolactone Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Polycaprolactone Market, including BASF SE, Corbion N.V., and Perstorp Holding AB, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced PCL products and explore new applications in high-growth markets. Collaborations with academic institutions, research organizations, and industry stakeholders facilitate market access and promote new product adoption. Emphasis on sustainability, high-quality products, and comprehensive marketing strategies fosters market growth and enhances brand loyalty in the evolving Polycaprolactone Market landscape.

Key Companies Profiled:

  • Perstorp Holding A. B.
  • BASF SE
  • Diacel Corporation
  • Sigma-Aldrich Corporation (Merck)
  • Durect Corporation
  • Corbion Purac
  • Shenzen Esun Industrial Co. Ltd.
  • Haihang Industries Co., Ltd.
  • Polysciences, Inc.
  • Shenzhen Polymtek Biomaterial Co. Ltd.

Polycaprolactone Market Industry Segmentation:

Form

  • Pellets
  • Nanosphere
  • Microsphere

Production Method

  • Ring Opening Polymerization
  • Polycondesation of Carboxylic Acid

Application

  • Thermoplastic Polyurethane
  • Healthcare
  • Others

Region

  • North America
  • Latin America
  • Europe
  • South East Asia & Pacific
  • MEA
  • Japan
  • China

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Taxonomy
  • 2.2. Market Definition

3. Market Viewpoint

  • 3.1. Parent Market Outlook
  • 3.2. Value Chain Analysis
  • 3.3. Life Cycle Analysis
  • 3.4. Energy Requirement for Polycaprolactone
  • 3.5. Key Regulation
  • 3.6. Macro-economic Factors
  • 3.7. Forecast Factors: Relevance and Impact

4. Market Dynamics

  • 4.1. Market Driver
  • 4.2. Market Restraints
  • 4.3. Market Trend
  • 4.4. Market opportunity

5. Impact of Covid-19 on Market

  • 5.1. Covid-19 The Situation Now
  • 5.2. Effects of National Lockdowns in Various Countries
  • 5.3. Scenarios for Economic Impact of Covid-19 Crisis
  • 5.4. Industries Affected by Coronavirus Outbreak Worldwide
  • 5.5. Projected Recovery for Hardest Hit Sectors
  • 5.6. Coronavirus Impact on The World of Work
  • 5.7. Impact of Covid-19 on Manufacturing Industry
  • 5.8. Manufacturing Purchasing Managers Index, 2024
  • 5.9. Impact of Covid-19 on Supply Chain Worldwide
  • 5.10. Planning & Managing During Covid-19 Pandemic
  • 5.11. Upcoming Pointers Business Leaders Should Focus On

6. Impact of Covid-19 on Polycaprolactone Market

  • 6.1. Covid-19 Impact v/s Value of Polycaprolactone Market, by Country 2020
  • 6.2. Polycaprolactone Sales Projection, 2020 During Covid-19 Pandemic
  • 6.3. Pre Covid-19 Market Forecasts v/s Post Covid-19 Market Forecasts

7. Global Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032

  • 7.1. Introduction
    • 7.1.1. Market Value Projections
    • 7.1.2. Market Volume (MT) Projections
    • 7.1.3. Market Size and Y-o-Y Growth
    • 7.1.4. Absolute $ Opportunity
  • 7.2. Global Pricing Analysis
  • 7.3. Intensity Mapping

8. Global Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032, By Form

  • 8.1. Introduction
  • 8.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Form, 2019-2023
  • 8.3. Current Market Size (US$ Mn) and Volume (Meters) Analysis and Forecast By Form, 2024-2032)
    • 8.3.1. Pellets
    • 8.3.2. Nano sphere
    • 8.3.3. Microsphere
  • 8.4. Market Attractiveness Analysis By Form

9. Global Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032, By Production Method

  • 9.1. Introduction
  • 9.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Production Method, 2019-2023
  • 9.3. Current Market Size (US$ Mn) and Volume (Meters) Analysis and Forecast By Production Method, 2024-2032)
    • 9.3.1. Ring Opening polymerization
    • 9.3.2. Polycondesation of carboxylic acid
  • 9.4. Market Attractiveness Analysis By Production Method

10. Global Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032, By Application

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Application, 2019-2023
  • 10.3. Current Market Size (US$ Mn) and Volume (Meters) Analysis and Forecast By Application, 2024-2032)
    • 10.3.1. Thermoplastic polyurethane
    • 10.3.2. Healthcare
    • 10.3.3. Others
  • 10.4. Market Attractiveness Analysis By Platform

11. Global Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032, By Region

  • 11.1. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Region, 2019-2023
  • 11.2. Current Market Size (US$ Mn) and Volume (Meters) Analysis and Forecast By Region, 2024-2032
    • 11.2.1. North America
    • 11.2.2. Latin America
    • 11.2.3. Europe
    • 11.2.4. South East Asia & Pacific (SEAP)
    • 11.2.5. Middle East & Africa (MEA)
    • 11.2.6. Japan
    • 11.2.7. China
  • 11.3. Market Attractiveness Analysis By Region

12. North America Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Market Segments (2019-2023)
  • 12.3. Market Size (US$ Mn) and Volume (Meters) Forecast By Market Segments (2024-2032)
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Form
    • 12.3.3. By Production method
    • 12.3.4. By Application
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Form
    • 12.4.3. By Production method
    • 12.4.4. By Application

13. Latin America Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Market Segments (2019-2023)
  • 13.3. Market Size (US$ Mn) and Volume (Meters) Forecast By Market Segments (2024-2032)
    • 13.3.1. By Country
      • 13.3.1.1. Brazil
      • 13.3.1.2. Mexico
      • 13.3.1.3. Rest of Latin America
    • 13.3.2. By Form
    • 13.3.3. By Production method
    • 13.3.4. By Application
  • 13.4. Drivers and Restraints: Impact Analysis
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Country
    • 13.5.2. By Form
    • 13.5.3. By Production method
    • 13.5.4. By Application

14. Europe Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Market Segments (2019-2023)
  • 14.3. Market Size (US$ Mn) and Volume (Meters) Forecast By Market Segments (2024-2032)
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. France
      • 14.3.1.3. U.K.
      • 14.3.1.4. Italy
      • 14.3.1.5. Russia
      • 14.3.1.6. BENELUX
      • 14.3.1.7. Nordic countries
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Form
    • 14.3.3. By Production method
    • 14.3.4. By Application
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Form
    • 14.4.3. By Production method
    • 14.4.4. By Application

15. South East Asia & Pacific (SEAP) Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Market Segments (2019-2023)
  • 15.3. Market Size (US$ Mn) and Volume (Meters) Forecast By Market Segments (2024-2032)
    • 15.3.1. By Country
      • 15.3.1.1. ASEAN
      • 15.3.1.2. India
      • 15.3.1.3. Korea
      • 15.3.1.4. ANZ
      • 15.3.1.5. Rest of SEAP
    • 15.3.2. By Form
    • 15.3.3. By Production method
    • 15.3.4. By Application
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Form
    • 15.4.3. By Production method
    • 15.4.4. By Application

16. China Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Market Segments (2019-2023)
  • 16.3. Market Size (US$ Mn) and Volume (Meters) Forecast By Market Segments (2024-2032)
    • 16.3.1. By Form
    • 16.3.2. By Production method
    • 16.3.3. By Application
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Form
    • 16.4.2. By Production method
    • 16.4.3. By Application

17. Japan Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Market Segments (2019-2023)
  • 17.3. Market Size (US$ Mn) and Volume (Meters) Forecast By Market Segments (2024-2032)
    • 17.3.1. By Form
    • 17.3.2. By Production method
    • 17.3.3. By Application
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Form
    • 17.4.2. By Production method
    • 17.4.3. By Application

18. Middle East & Africa (MEA) Polycaprolactone Market Analysis 2019-2023 and Forecast 2024-2032

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) and Volume (Meters) Analysis By Market Segments (2019-2023)
  • 18.3. Market Size (US$ Mn) and Volume (Meters) Forecast By Market Segments (2024-2032)
    • 18.3.1. By Country
      • 18.3.1.1. GCC
      • 18.3.1.2. Turkey
      • 18.3.1.3. South Africa
      • 18.3.1.4. Rest of Middle East & Africa
    • 18.3.2. By Form
    • 18.3.3. By Production method
    • 18.3.4. By Application
  • 18.4. Drivers and Restraints: Impact Analysis
  • 18.5. Market Attractiveness Analysis
    • 18.5.1. By Country
    • 18.5.2. By Form
    • 18.5.3. By Production method
    • 18.5.4. By Application

19. Competition Landscape (Manufactures)

  • 19.1. Market Share Analysis
  • 19.2. Competitive Landscape
  • 19.3. Market Volume share analysis
  • 19.4. Competition Dashboard
  • 19.5. Company Profiles
    • 19.5.1. Perstorp Holding A. B.
      • 19.5.1.1. Overview
      • 19.5.1.2. Product Portfolio
      • 19.5.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.1.4. Production Footprint
      • 19.5.1.5. Sales Footprint
      • 19.5.1.6. Channel Footprint
      • 19.5.1.7. Strategy Overview
        • 19.5.1.7.1. Marketing Strategy
        • 19.5.1.7.2. Product Strategy
        • 19.5.1.7.3. Channel Strategy
    • 19.5.2. BASF SE
      • 19.5.2.1. Overview
      • 19.5.2.2. Product Portfolio
      • 19.5.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.2.4. Production Footprint
      • 19.5.2.5. Sales Footprint
      • 19.5.2.6. Channel Footprint
      • 19.5.2.7. Strategy Overview
        • 19.5.2.7.1. Marketing Strategy
        • 19.5.2.7.2. Product Strategy
        • 19.5.2.7.3. Channel Strategy
    • 19.5.3. Diacel Corporation
      • 19.5.3.1. Overview
      • 19.5.3.2. Product Portfolio
      • 19.5.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.3.4. Production Footprint
      • 19.5.3.5. Sales Footprint
      • 19.5.3.6. Channel Footprint
      • 19.5.3.7. Strategy Overview
        • 19.5.3.7.1. Marketing Strategy
        • 19.5.3.7.2. Product Strategy
        • 19.5.3.7.3. Channel Strategy
    • 19.5.4. Sigma-Aldrich Corporation (Merck)
      • 19.5.4.1. Overview
      • 19.5.4.2. Product Portfolio
      • 19.5.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.4.4. Production Footprint
      • 19.5.4.5. Sales Footprint
      • 19.5.4.6. Channel Footprint
      • 19.5.4.7. Strategy Overview
        • 19.5.4.7.1. Marketing Strategy
        • 19.5.4.7.2. Product Strategy
        • 19.5.4.7.3. Channel Strategy
    • 19.5.5. Durect Corporation
      • 19.5.5.1. Overview
      • 19.5.5.2. Product Portfolio
      • 19.5.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.5.4. Production Footprint
      • 19.5.5.5. Sales Footprint
      • 19.5.5.6. Channel Footprint
      • 19.5.5.7. Strategy Overview
        • 19.5.5.7.1. Marketing Strategy
        • 19.5.5.7.2. Product Strategy
        • 19.5.5.7.3. Channel Strategy
    • 19.5.6. Corbion Purac
      • 19.5.6.1. Overview
      • 19.5.6.2. Product Portfolio
      • 19.5.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.6.4. Production Footprint
      • 19.5.6.5. Sales Footprint
      • 19.5.6.6. Channel Footprint
      • 19.5.6.7. Strategy Overview
        • 19.5.6.7.1. Marketing Strategy
        • 19.5.6.7.2. Product Strategy
        • 19.5.6.7.3. Channel Strategy
    • 19.5.7. Shenzen Esun Industrial Co. Ltd.
      • 19.5.7.1. Overview
      • 19.5.7.2. Product Portfolio
      • 19.5.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.7.4. Production Footprint
      • 19.5.7.5. Sales Footprint
      • 19.5.7.6. Channel Footprint
      • 19.5.7.7. Strategy Overview
        • 19.5.7.7.1. Marketing Strategy
        • 19.5.7.7.2. Product Strategy
        • 19.5.7.7.3. Channel Strategy
    • 19.5.8. Haihang Industries Co., Ltd.
      • 19.5.8.1. Overview
      • 19.5.8.2. Product Portfolio
      • 19.5.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.8.4. Production Footprint
      • 19.5.8.5. Sales Footprint
      • 19.5.8.6. Channel Footprint
      • 19.5.8.7. Strategy Overview
        • 19.5.8.7.1. Marketing Strategy
        • 19.5.8.7.2. Product Strategy
        • 19.5.8.7.3. Channel Strategy
    • 19.5.9. Polysciences, Inc.
      • 19.5.9.1. Overview
      • 19.5.9.2. Product Portfolio
      • 19.5.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.9.4. Production Footprint
      • 19.5.9.5. Sales Footprint
      • 19.5.9.6. Channel Footprint
      • 19.5.9.7. Strategy Overview
        • 19.5.9.7.1. Marketing Strategy
        • 19.5.9.7.2. Product Strategy
        • 19.5.9.7.3. Channel Strategy
    • 19.5.10. Shenzhen Polymtek Biomaterial Co. Ltd.
      • 19.5.10.1. Overview
      • 19.5.10.2. Product Portfolio
      • 19.5.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.5.10.4. Production Footprint
      • 19.5.10.5. Sales Footprint
      • 19.5.10.6. Channel Footprint
      • 19.5.10.7. Strategy Overview
        • 19.5.10.7.1. Marketing Strategy
        • 19.5.10.7.2. Product Strategy
        • 19.5.10.7.3. Channel Strategy

20. Research Methodology

21. Assumption & Acronyms Used